
HIMS
Hims & Hers Health Inc. Class A
Company Overview
| Mkt Cap | $9.60B | Price | $37.21 |
| Volume | 10.35M | Change | -1.48% |
| P/E Ratio | 76.2 | Open | $37.60 |
| Revenue | $1.5B | Prev Close | $37.77 |
| Net Income | $126.0M | 52W Range | $23.97 - $72.98 |
| Div Yield | N/A | Target | $45.73 |
| Overall | 36 | Value | 20 |
| Quality | 78 | Technical | 10 |
No chart data available
About Hims & Hers Health Inc. Class A
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest News
Insider Sales Shake Up Dell, Hims, Unity, T-Mobile, Southwest
Hims & Hers Health (HIMS) Bolsters UK Business with Launch of Weight-Loss Plans
HIMS Stock Forecast: Barclays Initiates With Buy Rating, Sees Over 20% Upside
Analysts Are Neutral on These Healthcare Stocks: Hims & Hers Health (HIMS), Cross Country Healthcare (CCRN)
M&A News: Him & Hers Snap Up ‘Pain Free’ Blood Testing Group YourBio
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HIMS | $37.21 | -1.5% | 10.35M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Hims & Hers Health Inc. Class A Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW